Business & regional news

Patient advocate and youth entrepreneur Grace Bowyer will join company executives, shining light on the critical importance for colon cancer screening

Medtronic today announced it received a license from Health Canada for its Symplicity Spyral™ multi-electrode Renal Denervation (RDN) System. This is indicated for the management of essential...

CRT 2024: Evolut TAVR is a safe, effective, and economically cost-effective treatment option for low-risk severe aortic stenosis patients compared to surgery up to four years

Katie will join colorectal cancer screening advocates and Medtronic leaders in a panel conversation, highlighting new data that reveals a stark gap in colorectal cancer awareness, as well as how AI is making the deadly disease more detectable, preventable

Medtronic, a global leader in medical technology, announced today the launch of the new UNiD™ ePRO service in the United States. This solution will change the way patient outcomes are collected...

Annual list highlights organizations leading the way in business integrity

• MEIC is the largest Research and Development (R&D) center outside the US. for Medtronic
• A 250,000 sq. ft. facility devoted to healthcare technology R&D in Hyderabad.

Doubled probe count enables multi-level spine tumor ablations for increased flexibility and efficiency Medtronic plc, a global leader in healthcare technology, today announced that it has received...

Medtronic will unveil the MiniMed™ 780G system with Simplera Sync™, a new disposable, all-in-one sensor.*

STROKE AF study shows long-term continuous cardiac monitoring delivers strong economic value driven by fewer projected lifetime strokes

FEBRUARY 6, 2024 – Hall of Fame Health and the Cranial and Spinal Technologies business of Medtronic, a global medical technology leader, today are announcing a partnership to advance health...

Physician feedback confirms clinical evidence: safe, efficient, and effective treatment offers most versatile new option for atrial fibrillation

86% of subjects preferred closed-loop SCS in a multicenter, randomized, crossover, single blind study of Medtronic’s investigational closed-loop SCS system at one month

24-month European RCT data demonstrates long-term superiority of DTM™ SCS compared with conventional medical management (CMM) for indicated chronic back pain patients not eligible for spine surgery

The Schwab Foundation for Social Entrepreneurship, a sister organization of the World Economic Forum (WEF), announced at WEF’s annual meeting in Davos today that Ruchika Singhal, president of Medtronic LABS, is the 2024 “Corporate Social Innovator of the Year.”

Strong environmental, social, and governance (ESG) management and performance result in continued inclusion on the Dow Jones Sustainability World Index

The next-generation DBS technology is now available in a rechargeable option

The PenditureTM Left Atrial Appendage (LAA) Exclusion System is
for the exclusion of the LAA in patients undergoing a concomitant cardiac surgery procedure.

Simplicity, efficiency, efficacy with unmatched safety data to set a new standard in catheter ablation

AHA23: Artificial intelligence (AI) applied to LINQ II™ ICMs reduce AF and pause (syncope) false alerts that can save clinics in the U.S. more than 400 hours per year

NOVA Study: On-label, prospective, multicenter, randomized controlled trial compared DTM™ SCS to conventional spinal cord stimulation

New guidelines will expand access to automated insulin delivery technology among wider population.

Next-Gen Evolut FX TAVI system enhances procedure ease-of-use, visualization, and predictability

Data shows the successful performance of the AID algorithm under substantial changes to daily routines and lifestyle, including during Ramadan.

NOTE: McGRATH™ MAC video laryngoscopes purchased directly from Medtronic or via its authorized distributors are not affected by this safety notice.

The company will initiate a phased launch of its disposable Simplera^TM CGM at the meeting, its smallest and most comfortable CGM to-date that’s integrated with the InPen^TM smart insulin pen

The ClosureFast™ catheter update brings new features including lower 6F profile and longer heating element for greater efficiency

• Improved survival with ICD therapy: nearly 25% lower risk of death in indicated patients receiving an ICD vs. no ICD
• ICDs confer additional long-term benefits after initial device replacement

40-site pilot program across US, UK, and Europe aims to introduce cutting edge AI solutions into the clinical environment to improve patient care and efficiency

The average UK surgeon loses four hours a week due to inefficient technology – equal to an entire working month each year. Nearly four in five surgeons say care would be easier to deliver with...

National Kidney Foundation and Medtronic survey found dialysis patients’ top concerns potentially better addressed by minimally invasive AV fistula creation procedures

Newly released guidance affirms safety in use of paclitaxel-coated medical devices in treatment of PAD

An additional 11 million Medicare beneficiaries will now have access to coverage for spinal cord stimulation therapy for the treatment of painful diabetic peripheral neuropathy

Orders will be processed immediately and shipments will start in the coming weeks

Results show that the use of InPen resulted in an increase in Time in Range among those in the studies ​

Together with Kings College Hospital, Medtronic has been awarded £2.5 million of government funding for a large-scale, real-world trial of GI Genius in NHS hospitals around the UK. The...

SCAI 2023 Scientific Sessions: Harmony™ Transcatheter Pulmonary Valve System Demonstrates Strong Clinical and Hemodynamic Outcomes at Two Years

Heart Rhythm 2023: Late-breaking analysis of the PULSED AF Trial reveals first of its kind significant, meaningful quality of life improvements and healthcare utilization benefits of the PulseSelect Pulsed Field Ablation System